Global Schizophrenia Therapeutics Report 2017 - Pipeline Review of 73 Companies & Drug Profiles - Research and Markets
What to do when your biotechnology stock gets hit by takeover rumors
What to do when your biotechnology stock gets -2-
Global Dry Powder Inhalers Report 2017: Products, Therapeutics, Players & Forecasts - Research and Markets
Morningstar analysts explain what makes the award winners stand out.
With the first half of 2005 in the rearview mirror, it's time for another review of how the stock star rating is doing. I'm happy to report that after lagging a bit in the first quarter, we've now pulled ahead of most of our benchmarks. The First Half of 2005 As a reminder, we measure our ...
With 2004 in the rearview mirror, I thought I'd share another Morningstar Rating for stocks performance review with you. Our results continue to be positive, which makes this a pleasant review to write. As before, we're measuring ourselves by creating a hypothetical portfolio that buys 5-star ...